ATP‑binding cassette transporter A1: A promising therapy target for prostate cancer (Review)
- Authors:
- Ting Xiong
- Gang Xu
- Xue‑Long Huang
- Kai‑Qiang Lu
- Wei‑Quan Xie
- Kai Yin
- Jian Tu
-
Affiliations: Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, P.R. China, Department of Diagnostics Teaching and Research, University of South China, Hengyang, Hunan 421001, P.R. China - Published online on: November 15, 2017 https://doi.org/10.3892/mco.2017.1506
- Pages: 9-14
This article is mentioned in:
Abstract
 |
|
Zong Y, Goldstein AS and Huang J: The molecular basis for ethnic variation and histological subtype differences in prostate cancer. Sci China Life Sci. 56:780–787. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Adlakha YK, Khanna S, Singh R, Singh VP, Agrawal A and Saini N: Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis. Cell Death Dis. 4:e7802013. View Article : Google Scholar : PubMed/NCBI | |
|
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, Cheng L, Masterson TA, Liu X, Ratliff TL and Cheng JX: Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 19:393–406. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Stopsack KH, Gerke TA, Andrén O, Andersson SO, Giovannucci EL, Mucci LA and Rider JR: Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Carcinogenesis. 38:806–811. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Cruz PM, Mo H, McConathy WJ, Sabnis N and Lacko AG: The role of cholesterol metabolism and cholesterol transport in carcinogenesis: A review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 4:1192013. View Article : Google Scholar : PubMed/NCBI | |
|
Flores K, Manautou JE and Renfro JL: Gender-specific expression of ATP-binding cassette (Abc) transporters and cytoprotective genes in mouse choroid plexus. Toxicology. 386:84–92. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Durmus S, Hendrikx JJ and Schinkel AH: Apical ABC transporters and cancer chemotherapeutic drug disposition. Adv Cancer Res. 125:1–41. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kaminski WE, Piehler A and Wenzel JJ: ABC A-subfamily transporters: Structure, function and disease. Biochim Biophys Acta. 1762:510–524. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Qian H, Zhao X, Cao P, Lei J, Yan N and Gong X: Structure of the human lipid exporter ABCA1. Cell. 169:1228–1239.e10. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Fitzgerald ML, Mendez AJ, Moore KJ, Andersson LP, Panjeton HA and Freeman MW: ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J Biol Chem. 276:15137–15145. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Lamping E, Baret PV, Holmes AR, Monk BC, Goffeau A and Cannon RD: Fungal PDR transporters: Phylogeny, topology, motifs and function. Fungal Genet Biol. 47:127–142. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lund-Katz S and Phillips MC: High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem. 51:183–227. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sene A, Khan AA, Cox D, Nakamura RE, Santeford A, Kim BM, Sidhu R, Onken MD, Harbour JW, Hagbi-Levi S, et al: Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 17:549–561. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S and Smith JD: ABCA1 and nascent HDL biogenesis. Biofactors. 40:547–554. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Murano T, Yamaguchi T, Tatsuno I, Suzuki M, Noike H, Takanami T, Yoshida T, Suzuki M, Hashimoto R, Maeno T, et al: Subfraction analysis of circulating lipoproteins in a patient with Tangier disease due to a novel ABCA1 mutation. Clin Chim Acta. 452:167–172. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bi DP, Yin CH, Zhang XY, Yang NN and Xu JY: MiR-183 functions as an oncogene by targeting ABCA1 in colon cancer. Oncol Rep. 35:2873–2879. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma M, Tuaine J, McLaren B, Waters DL, Black K, Jones LM and McCormick SP: Chemotherapy agents alter plasma lipids in breast cancer patients and show differential effects on lipid metabolism genes in liver cells. PLoS One. 11:e01480492016. View Article : Google Scholar : PubMed/NCBI | |
|
Kaneko T, Kanno C, Ichikawa-Tomikawa N, Kashiwagi K, Yaginuma N, Ohkoshi C, Tanaka M, Sugino T, Imura T, Hasegawa H and Chiba H: Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression. Oncotarget. 6:33345–33357. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sviridov DO, Drake SK, Freeman LA and Remaley AT: Amphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter. Biochem Biophys Res Commun. 471:560–565. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang M, Li L, Xie W, Wu JF, Yao F, Tan YL, Xia XD, Liu XY, Liu D, Lan G, et al: Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation. Atherosclerosis. 248:149–159. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Sultana A, Cochran BJ, Tabet F, Patel M, Torres LC, Barter PJ and Rye KA: Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I. FASEB J. 30:2324–2335. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Smith B and Land H: Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2:580–590. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Her NG, Jeong SI, Cho K, Ha TK, Han J, Ko KP, Park SK, Lee JH, Lee MG, Ryu BK and Chi SG: PPARδ promotes oncogenic redirection of TGF-β1 signaling through the activation of the ABCA1-Cav1 pathway. Cell Cycle. 12:1521–1535. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tazoe F, Yagyu H, Okazaki H, Igarashi M, Eto K, Nagashima S, Inaba T, Shimano H, Osuga J and Ishibashi S: Induction of ABCA1 by overexpression of hormone-sensitive lipase in macrophages. Biochem Biophys Res Commun. 376:111–115. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Dufour J, Viennois E, De Boussac H, Baron S and Lobaccaro JM: Oxysterol receptors, AKT and prostate cancer. Curr Opin Pharmacol. 12:724–728. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY and Liao S: Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res. 66:6482–6486. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lee BH, Taylor MG, Robinet P, Smith JD, Schweitzer J, Sehayek E, Falzarano SM, Magi-Galluzzi C, Klein EA and Ting AH: Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1. Cancer Res. 73:1211–1218. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao GJ, Yin K, Fu YC and Tang CK: The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol Med. 18:149–158. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tang C, Houston BA, Storey C and LeBoeuf RC: Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages. J Lipid Res. 57:848–857. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bochem AE, van der Valk FM, Tolani S, Stroes ES, Westerterp M and Tall AR: Increased systemic and plaque inflammation in ABCA1 mutation carriers with attenuation by statins. Arterioscler Thromb Vasc Biol. 35:1663–1669. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ramírez CM, Lin CS, Abdelmohsen K, Goedeke L, Yoon JH, Madrigal-Matute J, Martin-Ventura JL, Vo DT, Uren PJ, Penalva LO, et al: RNA binding protein HuR regulates the expression of ABCA1. J Lipid Res. 55:1066–1076. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ohno Y, Ohori M, Nakashima J, Okubo H, Satake N, Hashimoto T and Tachibana M: Association between preoperative serum total cholesterol level and biochemical recurrence in prostate cancer patients who underwent radical prostatectomy. Mol Clin Oncol. 4:1073–1077. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cardenas E and Ghosh R: Vitamin E: A dark horse at the crossroad of cancer management. Biochem Pharmacol. 86:845–852. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kaminski WE, Piehler A, Püllmann K, Porsch-Ozcürümez M, Duong C, Bared GM, Büchler C and Schmitz G: Complete coding sequence, promoter region, and genomic structure of the human ABCA2 gene and evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun. 281:249–258. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Paolini A, Baldassarre A, Del Gaudio I and Masotti A: Structural features of the ATP-Binding Cassette (ABC) transporter ABCA3. Int J Mol Sci. 16:19631–19644. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kubo Y, Sekiya S, Ohigashi M, Takenaka C, Tamura K, Nada S, Nishi T, Yamamoto A and Yamaguchi A: ABCA5 resides in lysosomes, and ABCA5 knockout mice develop lysosomal disease-like symptoms. Mol Cell Biol. 25:4138–4149. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Broccardo C, Osorio J, Luciani MF, Schriml LM, Prades C, Shulenin S, Arnould I, Naudin L, Lafargue C, Rosier M, et al: Comparative analysis of the promoter structure and genomic organization of the human and mouse ABCA7 gene encoding a novel ABCA transporter. Cytogenet Cell Genet. 92:264–270. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Piehler A, Kaminski WE, Wenzel JJ, Langmann T and Schmitz G: Molecular structure of a novel cholesterol-responsive A subclass ABC transporter, ABCA9. Biochem Biophys Res Commun. 295:408–416. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Maeß MB, Stolle K, Cullen P and Lorkowski S: Evidence for an alternative genomic structure, mRNA and protein sequence of human ABCA13. Gene. 515:298–307. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Marques RB, Aghai A, de Ridder CMA, Stuurman D, Hoeben S, Boer A, Ellston RP, Barry ST, Davies BR, Trapman J and van Weerden WM: High efficacy of combination therapy Using PI3K/AKT inhibitors with androgen deprivation in prostate cancer preclinical models. Eur Urol. 67:1177–1185. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Okoro EU, Guo Z and Yang H: Akt isoform-dependent regulation of ATP-Binding cassette A1 expression by apolipoprotein E. Biochem Biophys Res Commun. 477:123–128. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Gabitova L, Restifo D, Gorin A, Manocha K, Handorf E, Yang DH, Cai KQ, Klein-Szanto AJ, Cunningham D, Kratz LE, et al: Endogenous sterol metabolites regulate growth of EGFR/KRAS-dependent tumors via LXR. Cell Rep. 12:1927–1938. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Solomon KR, Allott EH, Freeman MR and Freedland SJ: Words of wisdom. Re: Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1. Eur Urol. 63:1128–1129. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hayashi N, Matsushima M, Yamamoto T, Sasaki H, Takahashi H and Egawa S: The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years. BJU Int. 109:515–519. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chou JL, Huang RL, Shay J, Chen LY, Lin SJ, Yan PS, Chao WT, Lai YH, Lai YL, Chao TK, et al: Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients. Clin Epigenetics. 7:12015. View Article : Google Scholar : PubMed/NCBI | |
|
He C and Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Puri P and Chandra A: Autophagy modulation as a potential therapeutic target for liver diseases. J Clin Exp Hepatol. 4:51–59. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Han XB, Li HX, Jiang YQ, Wang H, Li XS, Kou JY, Zheng YH, Liu ZN, Li H, Li J, et al: Upconversion nanoparticle-mediated photodynamic therapy induces autophagy and cholesterol efflux of macrophage-derived foam cells via ROS generation. Cell Death Dis. 8:e28642017. View Article : Google Scholar : PubMed/NCBI | |
|
Lin XL, Liu MH, Hu HJ, Feng HR, Fan XJ, Zou WW, Pan YQ, Hu XM and Wang Z: Curcumin enhanced cholesterol efflux by upregulating ABCA1 expression through AMPK-SIRT1-LXRα signaling in THP-1 macrophage-derived foam cells. DNA Cell Biol. 34:561–572. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang Y, Kou J, Han X, Li X, Zhong Z, Liu Z, Zheng Y, Tian Y and Yang L: ROS-dependent activation of autophagy through the PI3K/Akt/mTOR pathway is induced by hydroxysafflor yellow A-sonodynamic therapy in THP-1 macrophages. Oxid Med Cell Longev. 2017:85191692017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Daniels G, Lee P and Monaco ME: Lipid metabolism in prostate cancer. Am J Clin Exp Urol. 2:111–120. 2014.PubMed/NCBI | |
|
Brusselmans K, Timmermans L, Van de Sande T, Van Veldhoven PP, Guan G, Shechter I, Claessens F, Verhoeven G and Swinnen JV: Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. J Biol Chem. 282:18777–18785. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Jia XH, Chen JR, Yi YJ, Wang JY, Li YJ and Xie SY: HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway. Int J Oncol. 49:2529–2537. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JR, Jia XH, Wang H, Yi YJ, Wang JY and Li YJ: Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Int J Oncol. 48:2063–2070. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mo W, Zhang J, Li X, Meng D, Gao Y, Yang S, Wan X, Zhou C, Guo F, Huang Y, et al: Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer. PLoS One. 8:e565922013. View Article : Google Scholar : PubMed/NCBI | |
|
Sekine Y, Demosky SJ, Stonik JA, Furuya Y, Koike H, Suzuki K and Remaley AT: High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Mol Cancer Res. 8:1284–1294. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chisaki I, Kobayashi M, Itagaki S, Hirano T and Iseki K: Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver. Biochim Biophys Acta. 1788:2396–2403. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kimura Y, Morita SY, Matsuo M and Ueda K: Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci. 98:1303–1310. 2007. View Article : Google Scholar : PubMed/NCBI |
